Lethality in a murine model of pulmonary anthrax is reduced by combining nuclear transport modifier with antimicrobial therapy.

Veach RA, Zienkiewicz J, Collins RD, Hawiger J
PLoS One. 2012 7 (1): e30527

PMID: 22291977 · PMCID: PMC3266913 · DOI:10.1371/journal.pone.0030527

MeSH Terms (16)

Active Transport, Cell Nucleus Animals Anthrax Anti-Infective Agents Cell-Penetrating Peptides Ciprofloxacin Cytokines Disease Models, Animal Drug Combinations Female Lung Diseases Membrane Proteins Mice Peptides, Cyclic Survival Analysis Treatment Outcome

Connections (3)

This publication is referenced by other Labnodes entities: